Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6531
    +0.0008 (+0.12%)
     
  • OIL

    83.90
    +0.33 (+0.39%)
     
  • GOLD

    2,346.50
    +4.00 (+0.17%)
     
  • Bitcoin AUD

    97,501.13
    -1,128.94 (-1.14%)
     
  • CMC Crypto 200

    1,324.94
    -71.60 (-5.12%)
     
  • AUD/EUR

    0.6104
    +0.0031 (+0.51%)
     
  • AUD/NZD

    1.0990
    +0.0033 (+0.30%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,740.50
    +310.00 (+1.78%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,295.08
    +209.28 (+0.55%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Is CRISPR Therapeutics a Millionaire-Maker Stock?

Is CRISPR Therapeutics a Millionaire-Maker Stock?

Today, let's turn our attention to gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP). The stock market performance of a clinical-stage biotech like CRISPR Therapeutics is largely tied to the perceived successes (or potential failures) of its pipeline candidates. The company's approach centers on gene editing, which refers to a set of techniques that allow scientists to modify an organism's DNA.